SPL 1.08% 9.4¢ starpharma holdings limited

Ann: SPL7013 COVID-19 nasal spray virucidal against SARS-CoV-2, page-130

  1. 15,419 Posts.
    lightbulb Created with Sketch. 5520
    Perhaps time for Starpharma to actually do something with DEP Remdesivir and Gilead instead of just 'chatting'

    https://www.medpagetoday.com/infectiousdisease/covid19/90008

    NIH Guidelines Shrink Scope of Remdesivir Use in COVID-19

    — Only dexamethasone now listed for sickest patients

    Updated National Institutes of Health guidelines narrowed the scope of recommended use for remdesivir (Veklury) in hospitalized COVID-19 patients, and the quality of evidence backing the drug's use also took a hit.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.